This record was last updated November 29, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an open label study to evaluate the safety and efficacy of β-globin Restored Autologous Hematopoietic Stem Cells in ß-Thalassemia Major Patients
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-24; most recent amendment 2024-11-26.